Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/23/2017 05/24/2017 05/25/2017 05/26/2017 05/29/2017 Date
118.05(c) 117.65(c) 116.75(c) 116.7(c) 116.35 Last
1 949 942 1 267 841 1 206 780 1 425 565 373 816 Volume
+1.24% -0.34% -0.76% -0.04% -0.30% Change
More quotes
Financials (€)
Sales 2017 50 026 M
EBIT 2017 9 706 M
Net income 2017 5 752 M
Debt 2017 10 907 M
Yield 2017 2,45%
Sales 2018 52 566 M
EBIT 2018 10 150 M
Net income 2018 6 145 M
Debt 2018 8 336 M
Yield 2018 2,65%
P/E ratio 2017 17,70
P/E ratio 2018 16,47
EV / Sales2017 2,15x
EV / Sales2018 1,99x
Capitalization 96 505 M
More Financials
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
07/27Earnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
01:02p WARREN BUFFETT : Warren Buffett takes 3 percent stake in Germany's Lanxess
05/26 COVESTRO : names new CEO to replace Patrick Thomas
05/25 BAYER : Findings from Bayer Has Provided New Data on Non-Small Cell Lung Cancer ..
05/24 BAYER : Federal Contracts Awarded by Federal Agencies in Connecticut (May 24)
05/24 DGAP-ADHOC : Covestro AG: CEO succession planning
05/24 Freeze Drying Agenda Released for Lyophilization USA 2017
05/23 GLOBAL HERBICIDE RESISTANCE CHALLENG : Adrian Percy: ”We invest in finding..
05/23 BAYER : $165,000 Federal Contract Awarded to iMed Biomedical
05/20 COVESTRO : to expand CO2-using processes
05/19 BAYER : Combine Solicitation - MEDRAD Injector Maintenance
More news
Sector news : Pharmaceuticals - NEC
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER AG 
2016Good timing to anticipate the return of volatility
2016A technical turn-around configuration
More Strategies
Latest Tweets
12:42aBayer AG $BAYRY Receives Consensus Rating of “Buy” from Brokerages  
05/26World Radiation Dose Management Market Report 2017 - Key Players are Fujifilm.. 
05/26Covestro AG given €86.00 PT by Jefferies Group LLC. buy rating.  
05/24This one of a kind piece of furniture is made using Covestro materials ??
3
05/24NEWS: Changes at the top of Covestro’s Board of Management by end of Q3 2018...
22
More tweets
Qtime:44
News from SeekingAlpha
05/23 Mergers And Acquisitions - Capturing The Gain (Of Acquirees)
05/21 Tracking Dan Loeb's Third Point Portfolio - Q1 2017 Update
05/18 3 THINGS IN BIOTECH YOU SHOULD LEARN : May 18, 2017
05/18 Bayer on deck with nine abstracts at ASCO
05/17 FDA grants Priority Review for Bayer's NDA for copanlisib for follicular lymp..
Advertisement
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 118 €
Spread / Average Target 1,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG17.72%107 863
JOHNSON & JOHNSON10.16%341 901
ROCHE HOLDING LTD.14.62%236 581
NOVARTIS AG6.07%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results